Redefining response to Cardiac Resynchronisation Therapy: A Post-hoc Analysis of the MORE-CRT MPP trial
Clicks: 1
ID: 324593
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
0.0
/100
1 views
0 readers
AI Quality Assessment
Not analyzed
Readership in this journal
Ranked #78 of 83 articles by views in EP Europace
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
BACKGROUND: Cardiac resynchronization therapy (CRT) response is commonly assessed at 6 months using left ventricular end-systolic volume (LVESV) and clinical endpoints. Some initial non-responders may improve or stabilize by 12 months. OBJECTIVES: To determine outcomes and predictors of echocardiographic response trajectories and evaluate the clinical course of patients who stabilised or deteriorated after 6 months. METHODS: This post-hoc analysis of the MORE-CRT MPP trial included patients receiving conventional biventricular pacing only. Patients were classified as non-responders (<15% LVESV reduction at 6 and 12 months), early responders (>15% reduction at 6 months), or delayed responders (<15% reduction at 6 months but >15% at 12 months). Six-month non-responders were further classified as stabilised (LVESV reduction at 12 months) or deteriorated (LVESV increase at 12 months). Heart failure hospitalization (HFH) or death was analysed using restricted mean survival time and adjusted accelerated failure time models. RESULTS: Among 2,732 patients (69.4% male; 62.8% non-ischaemic), event-free survival differed between early, delayed, and non-responders (p<0.001). Non-responders had 52% shorter event-free survival than early responders (p<0.001), and 38% shorter than delayed responders (p=0.025). Early and delayed responders had similar outcomes (p=0.221). Among non-responders, 39.0% stabilised and 61.0% deteriorated; outcomes diverged after 6 months (p<0.001). The deterioration group had 59% shorter event-free survival (p<0.001). Ischaemic aetiology, non-LBBB, and lower baseline LVEF predicted delayed response. CONCLUSIONS: Delayed responders demonstrated similarly favourable clinical outcomes to early responders over the duration of follow-up. These findings support 12-month assessment and trajectory-based definitions of CRT response.
| Reference Key |
openalex_W7202119359
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Vishal Mehta, Nadeev Wijesuriya, Felicity De Vere, Sandra Howell, Mark K. Elliott, Alphonsus Liew, Steven Niederer, Haran Burri, Johannes Sperzel, Leonardo Calò, Bernard Thibault, Wenjiao Lin, Kwangdeok Lee, Andrea Grammatico, Niraj Varma, Marianne Gwechenberger, Giuseppe Boriani, Christophe Leclercq, Christopher A. Rinaldi |
| Journal | EP Europace |
| Year | 2026 |
| DOI |
10.1093/europace/euag209
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.